SCHIMMEL PAUL

CIK 00012364476 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001236447

Recent Transactions

50 trades

Purchase
aTYR PHARMA INC$ATYR
Common Stock
2025-10-09$0.94/sh+317,999→ 1,413,023 total
Purchase
aTYR PHARMA INC$ATYR
Common Stock
2025-10-08$0.90/sh+682,001→ 1,095,024 total
Award
aTYR PHARMA INC$ATYR
Stock Option (right to buy)
2025-05-01+50,000→ 50,000 total
Purchase
aTYR PHARMA INC$ATYR
Common Stock
2024-07-24$1.93/sh+52,300→ 413,023 total
Purchase
aTYR PHARMA INC$ATYR
Common Stock
2024-07-23$1.82/sh+6,648→ 360,723 total
Purchase
aTYR PHARMA INC$ATYR
Common Stock
2024-07-22$1.74/sh+41,052→ 354,075 total
Award
aTYR PHARMA INC$ATYR
Stock Option (right to buy)
2024-05-22+24,000→ 24,000 total
Award
aTYR PHARMA INC$ATYR
Stock Option (right to buy)
2023-05-17+12,000→ 12,000 total
Purchase
aTYR PHARMA INC$ATYR
Common Stock
2023-05-10$2.25/sh+200,000→ 313,023 total
Exercise/Conversion
aTYR PHARMA INC$ATYR
Restricted Stock Unit
2023-04-26−6,000→ 0 total
Exercise/Conversion
aTYR PHARMA INC$ATYR
Common stock
2023-04-26+6,000→ 8,890 total
Award
aTYR PHARMA INC$ATYR
Restricted Stock Units
2022-04-26+6,000→ 6,000 total
Gift
aTYR PHARMA INC$ATYR
Common Stock
2021-09-20−250,000→ 2,890 total
Gift
aTYR PHARMA INC$ATYR
Common Stock
2021-09-20+250,000→ 679,143 total
Purchase
aTYR PHARMA INC$ATYR
Common Stock
2021-09-20$8.00/sh+250,000→ 252,890 total
Purchase
aTYR PHARMA INC$ATYR
Common Stock
2021-05-18$3.98/sh+50,000→ 113,023 total
Award
aTYR PHARMA INC$ATYR
Stock Option (right to buy)
2021-04-28+1,428→ 1,428 total
Sale
aTYR PHARMA INC$ATYR
Common Stock
2020-05-20$3.64/sh−8,447→ 429,143 total
Award
aTYR PHARMA INC$ATYR
Stock Option (right to buy)
2020-05-06+1,428→ 1,428 total
Purchase
aTYR PHARMA INC$ATYR
Common Stock
2020-02-10$4.25/sh+254,000→ 437,590 total
Award
Forte Biosciences, Inc.$FBRX
Stock Option (right to buy)
2019-10-04+7,500→ 7,500 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2019-07-01+9,000→ 9,000 total
Award
Forte Biosciences, Inc.$FBRX
Stock option (right to buy)
2019-05-29+20,000→ 20,000 total
Award
aTYR PHARMA INC$ATYR
Stock Option (right to buy)
2019-05-08+20,000→ 20,000 total
Award
aTYR PHARMA INC$ATYR
Common Stock
2019-04-12$0.54/sh+1,848,428→ 2,570,242 total
Purchase
aTYR PHARMA INC$ATYR
Common Stock
2018-11-26$0.54/sh+147,225→ 882,302 total
Purchase
aTYR PHARMA INC$ATYR
Common Stock
2018-09-04$0.76/sh+20,749→ 735,077 total
Purchase
aTYR PHARMA INC$ATYR
Common Stock
2018-08-31$0.72/sh+22,000→ 714,328 total
Purchase
aTYR PHARMA INC$ATYR
Common Stock
2018-08-30$0.76/sh+89,275→ 692,328 total
Purchase
aTYR PHARMA INC$ATYR
Common Stock
2018-08-29$0.72/sh+75,136→ 603,053 total
Award
Forte Biosciences, Inc.$FBRX
Stock option (right to buy)
2018-06-21+20,000→ 20,000 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2018-06-20+9,000→ 9,000 total
Purchase
aTYR PHARMA INC$ATYR
Common Stock
2018-05-18$1.00/sh+150,000→ 527,917 total
Award
aTYR PHARMA INC$ATYR
Stock Option (right to buy)
2018-05-15+20,000→ 20,000 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2018-03-13$59.25/sh+15,000→ 27,823 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2018-03-13$150.00/sh−27,823→ 0 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2018-03-13−15,000→ 0 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2018-03-13$63.86/sh+2,823→ 12,823 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2018-03-13−10,000→ 0 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2018-03-13$30.09/sh+10,000→ 10,000 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2018-03-13−2,823→ 0 total
Purchase
aTYR PHARMA INC$ATYR
Warrant to Purchase Common Stock
2017-08-31+35,376→ 35,376 total
Purchase
aTYR PHARMA INC$ATYR
Common Stock
2017-08-31$2.65/sh+94,336→ 377,917 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2017-06-02+11,250→ 11,250 total
Award
aTYR PHARMA INC$ATYR
Stock Option (right to buy)
2017-05-09+20,000→ 20,000 total
Conversion
Forte Biosciences, Inc.$FBRX
Series F Preferred Stock
2017-04-19−28,410→ 0 total
Conversion
Forte Biosciences, Inc.$FBRX
Series G Preferred Stock
2017-04-19−25,000→ 0 total
Conversion
Forte Biosciences, Inc.$FBRX
Series H Preferred Stock
2017-04-19−161,906→ 0 total
Conversion
Forte Biosciences, Inc.$FBRX
Common Stock
2017-04-19+4,117→ 4,117 total
Conversion
Forte Biosciences, Inc.$FBRX
Series G Preferred Stock
2017-04-19−25,000→ 0 total

SCHIMMEL PAUL

Recent Transactions

Companies

Recent Filings

Address